Cogent Biosciences, Inc. (COGT)
34.43
-0.24
(-0.69%)
USD |
NASDAQ |
Aug 31, 10:29
Cogent Biosciences Cash and Short Term Investments (Quarterly) : 792.30M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 792.30M |
| March 31, 2026 | 866.38M |
| December 31, 2025 | 900.76M |
| September 30, 2025 | 390.89M |
| June 30, 2025 | 237.85M |
| March 31, 2025 | 245.66M |
| December 31, 2024 | 287.08M |
| September 30, 2024 | 335.52M |
| June 30, 2024 | 363.22M |
| March 31, 2024 | 435.74M |
| December 31, 2023 | 265.71M |
| September 30, 2023 | 279.04M |
| June 30, 2023 | 329.40M |
| March 31, 2023 | 221.52M |
| December 31, 2022 | 260.53M |
| September 30, 2022 | 290.35M |
| June 30, 2022 | 326.82M |
| March 31, 2022 | 191.05M |
| Date | Value |
|---|---|
| December 31, 2021 | 219.68M |
| September 30, 2021 | 202.89M |
| June 30, 2021 | 218.10M |
| March 31, 2021 | 230.74M |
| December 31, 2020 | 242.19M |
| September 30, 2020 | 129.42M |
| June 30, 2020 | 21.34M |
| March 31, 2020 | 29.60M |
| December 31, 2019 | 37.42M |
| September 30, 2019 | 45.88M |
| June 30, 2019 | 55.86M |
| March 31, 2019 | 67.10M |
| December 31, 2018 | 78.59M |
| September 30, 2018 | 87.12M |
| June 30, 2018 | 94.50M |
| March 31, 2018 | 32.45M |
| December 31, 2017 | 41.04M |
| September 30, 2017 | 48.38M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | 971.93M |
| Erasca, Inc. | 268.74M |
| Moderna, Inc. | 5.138B |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |